Prospective, double-blind, randomized, placebo-controlled study of raloxifene and paroxetine studying reporting of hot flashes in postmenopausal women

Trial Profile

Prospective, double-blind, randomized, placebo-controlled study of raloxifene and paroxetine studying reporting of hot flashes in postmenopausal women

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2014

At a glance

  • Drugs Paroxetine (Primary) ; Raloxifene (Primary)
  • Indications Hot flashes
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top